Gary Sender
CIK 1659085 · Chief Financial Officer · last filed 2026-05-18
Gary Sender is a Chief Financial Officer who has filed 43 SEC Form 4 insider transactions across 4 companies since 2017. The most recent filing, for HRMY, was dated May 18, 2026. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $264.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$264.8K
4
43
-$1.87M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HRMY | Director | — | $34.46 | — | $0 | 7 | 2026-05-18 |
| IBIO | Director | 9,191 | $1.69 | $15.5K | $25.0K | 5 | 2025-11-24 |
| SDGR | Director | 17,247 | $14.45 | $249.2K | -$1.91M | 7 | 2025-06-20 |
| Nabriva Therapeutics plc (NBRV) Delisted | Chief Financial Officer | 20,472 | $1.42 | $29.1K | $18.5K | 23 | 2021-03-02 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | HRMY | Grant (A) | — | $0 | EDGAR |
| 2025-11-24 | IBIO | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | SDGR | Grant (A) | +5,997 | $0 | EDGAR |
| 2025-05-16 | HRMY | Grant (A) | — | $0 | EDGAR |
| 2025-01-13 | IBIO | Buy (P) | +9,191 | $25.0K | EDGAR |
| 2024-11-25 | IBIO | Grant (A) | — | $0 | EDGAR |
| 2024-06-20 | SDGR | Grant (A) | +5,000 | $0 | EDGAR |
| 2024-05-31 | HRMY | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | SDGR | Grant (A) | +6,250 | $0 | EDGAR |
| 2023-05-26 | HRMY | Grant (A) | — | $0 | EDGAR |